TAYSOFY
These highlights do not include all the information needed to use TAYSOFY safely and effectively. See full prescribing information for . norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), for oral use Initial U.S. Approval: 1968
Approved
Approval ID
5b7b33cf-7b58-4ba2-b819-9cd4602edc8b
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 3, 2022
Manufacturers
FDA
Amneal Pharmaceuticals LLC
DUNS: 123797875
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Norethindrone Acetate and Ethinyl Estradiol, and Ferrous Fumarate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code65162-558
Application NumberANDA214292
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norethindrone Acetate and Ethinyl Estradiol, and Ferrous Fumarate
Product Specifications
Route of AdministrationORAL
Effective DateJune 3, 2022
FDA Product Classification